Conditioned medium mimicking the tumor microenvironment augments chemotherapeutic resistance via ataxia‑telangiectasia mutated and nuclear factor‑κB pathways in gastric cancer cells

Oncol Rep. 2018 Oct;40(4):2334-2342. doi: 10.3892/or.2018.6637. Epub 2018 Aug 7.

Abstract

The tumor microenvironment affects the processes involved in the development of gastric cancer and contributes to multidrug resistance (MDR). Although the metabolism of gastric cancer cells is known to be associated with the development of the tumor microenvironment, the exact role of metabolism in microenvironment‑induced MDR formation remains unclear. In the present study, conditioned medium (CM) formed through the metabolism of SGC‑7901 gastric carcinoma cells was used to mimic the tumor microenvironment. The effects of CM on drug resistance were evaluated in gastric carcinoma cells. The results revealed that CM was not only able to upregulate the expression levels of ATP‑binding cassette subfamily G member 2 (ABCG2) and MDR‑associated protein 2 (MRP2), but also upregulated the expression of certain anti‑apoptotic proteins in SGC‑7901 cells. In addition, CM activated the ataxia‑telangiectasia mutated (ATM) and NF‑κB pathways, while CM‑induced ABCG2, MRP2 and anti‑apoptotic protein upregulation was impaired by ATM and NF‑κB inhibitors. The results of the present study indicated that CM augmented chemotherapeutic resistance by activating the ATM and NF‑κB pathways in gastric cancer cells, and that these pathways may be potential therapeutic targets for cases of chemotherapeutic resistance in gastric cancer.

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily G, Member 2 / genetics
  • ATP Binding Cassette Transporter, Subfamily G, Member 2 / metabolism*
  • Antineoplastic Agents / pharmacology
  • Apoptosis / drug effects
  • Ataxia Telangiectasia Mutated Proteins / genetics
  • Ataxia Telangiectasia Mutated Proteins / metabolism*
  • Biomarkers, Tumor / genetics
  • Biomarkers, Tumor / metabolism*
  • Cell Proliferation / drug effects
  • Cisplatin / pharmacology
  • Culture Media, Conditioned / pharmacology*
  • Drug Resistance, Neoplasm / drug effects*
  • Gene Expression Regulation, Neoplastic / drug effects
  • Humans
  • Multidrug Resistance-Associated Protein 2
  • Multidrug Resistance-Associated Proteins / genetics
  • Multidrug Resistance-Associated Proteins / metabolism
  • NF-kappa B / genetics
  • NF-kappa B / metabolism*
  • Neoplasm Proteins / genetics
  • Neoplasm Proteins / metabolism*
  • Signal Transduction / drug effects
  • Stomach Neoplasms / drug therapy
  • Stomach Neoplasms / metabolism
  • Stomach Neoplasms / pathology*
  • Tumor Cells, Cultured
  • Tumor Microenvironment / drug effects*

Substances

  • ABCC2 protein, human
  • ABCG2 protein, human
  • ATP Binding Cassette Transporter, Subfamily G, Member 2
  • Antineoplastic Agents
  • Biomarkers, Tumor
  • Culture Media, Conditioned
  • Multidrug Resistance-Associated Protein 2
  • Multidrug Resistance-Associated Proteins
  • NF-kappa B
  • Neoplasm Proteins
  • ATM protein, human
  • Ataxia Telangiectasia Mutated Proteins
  • Cisplatin